Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16 - Wikidata - awgldk - TriplyDB

Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16

Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16

http://www.wikidata.org/entity/Q33602223

about

Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality Unexploited Antineoplastic Effects of Commercially Available Anti-Diabetic Drugs Current understanding of metformin effect on the control of hyperglycemia in diabetes Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review Metformin and the risk of cancer: time-related biases in observational studies Old drug, new trick: repurposing metformin for gynecologic cancers?Cellular and molecular mechanisms of metformin: an overview The association between type 2 diabetes mellitus and women cancer: the epidemiological evidences and putative mechanisms Diabetes and cancer: a consensus report.Metformin and trametinib have synergistic effects on cell viability and tumor growth in NRAS mutant cancer.Update on the treatment of type 2 diabetes mellitus Association between Gastroenterological Malignancy and Diabetes Mellitus and Anti-Diabetic Therapy: A Nationwide, Population-Based Cohort Study Deciphering Signaling Pathway Networks to Understand the Molecular Mechanisms of Metformin Action HbA1c measured in stored erythrocytes is positively linearly associated with mortality in individuals with diabetes mellitus Significantly increased risk of cancer in diabetes mellitus patients: A meta-analysis of epidemiological evidence in Asians and non-Asians.Design of the e-Vita diabetes mellitus study: effects and use of an interactive online care platform in patients with type 2 diabetes (e-VitaDM-1/ZODIAC-40).Use of metformin and survival of diabetic women with breast cancer Potential biomarker of metformin action.AMPK activation--protean potential for boosting healthspan.Effects of prolonged exposure to low dose metformin in thyroid cancer cell lines.Diabetes and cancer: Associations, mechanisms, and implications for medical practice.Role of metformin in suppressing 1,2-dimethylhydrazine-induced colon cancer in diabetic and non-diabetic mice: effect on tumor angiogenesis and cell proliferation Understanding the benefit of metformin use in cancer treatment.Long-term metformin use is associated with decreased risk of breast cancer.Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma.Diabetes mellitus, fasting glucose, and risk of cause-specific death.Low concentrations of metformin suppress glucose production in hepatocytes through AMP-activated protein kinase (AMPK).Diabetes and cancer II: role of diabetes medications and influence of shared risk factors.The genetic basis of kidney cancer: a metabolic disease The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies.Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders.AMPK reverses the mesenchymal phenotype of cancer cells by targeting the Akt-MDM2-Foxo3a signaling axis.Metformin and cancer.The proliferating role of insulin and insulin-like growth factors in cancer.Glargine safety, diabetes and cancer.Synergistic anti-cancer effect of phenformin and oxamate.Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis.Metformin for aging and cancer prevention.Different patterns of Akt and ERK feedback activation in response to rapamycin, active-site mTOR inhibitors and metformin in pancreatic cancer cells.Diabetes and pancreatic cancer.

P2860

Q24745996-DC4E2BED-AC66-4730-B598-829510FC7D03 Q26750845-964B7919-A0B5-492B-B969-CAAEEB4B33D4 Q26770236-13C08AE1-1187-454C-9676-2BC37C24AE7D Q26850912-1D23A792-210B-48FA-8AF2-4D5D53972664 Q26999266-E999DBF7-9707-440C-989C-9D357BC59A44 Q27010558-34E3C0C4-A654-4202-9D27-821A72477B3A Q27013561-501C9539-6062-425D-936C-90559948DEC8 Q27026813-4F68E95B-EDFC-47CA-836A-F42E20CE60F3 Q27686977-3BA53FE0-B56E-4F1E-B00D-67D4C193E2DD Q27853104-7AC30045-184B-4BE9-AAA6-2A04F0CB0A30 Q28073342-01200623-8947-4CBA-8860-C0F0A1C20F6F Q28547270-F34CCD00-6B80-4FC7-BCB0-C9AFB430C2EE Q28548411-0FA3EFB5-4BF0-403D-956C-FC782FF4B6E6 Q28728521-E9741376-50CF-4A63-B950-80F502AA053D Q33585663-E62D0E28-F06E-4708-9081-709DD9BA5ED0 Q33591241-96C73826-0A7A-44E9-A453-98247ADB9065 Q33646542-4B68E601-8A6E-42FB-8473-BF663014C2D3 Q33686430-0E515EAE-DC6C-4CBB-9747-D0597409DD38 Q33689169-6C50AB02-B870-4565-85E9-B6A4E0084CBC Q33702357-FBCD1A69-018B-4406-B814-7AC04FF3EBFD Q33759594-EF8BDB38-7F53-4943-8504-DDBB526F7003 Q33817206-382BC045-DA9B-4CD9-B0EB-D44FDABD7163 Q33864199-DD22FDD3-4AFA-4ADA-B190-C579F4E0527C Q33873130-758FE0BE-47B3-4A3F-AD54-C906EC4AA997 Q33935606-BBCFE4CA-9917-4D1C-8953-FAC0CC9D92C9 Q33945937-90D4BB6E-C372-44AC-8ABB-1792E313C696 Q33946957-82246A6C-A318-429A-8874-0B042CD56A70 Q34069086-9D66CB84-D39C-41A6-A741-20FCD2DC16F4 Q34087148-65208BEF-46CA-431E-958E-E36D133551AC Q34113485-01D34005-8D04-410F-89BB-4562EB0E7E65 Q34135248-422DFAB0-5D8B-48A8-AEE3-BFE804F2AC4C Q34135442-7615B9BC-C9F2-4C53-B33A-EC77600B712B Q34159241-A4A6226B-2BFD-4A7B-A1C2-460FDE0003A9 Q34172625-65B64C5D-267E-4C04-B5F9-1E6A17759F21 Q34326924-871E364C-0370-4ECD-B883-5F88C4F32D97 Q34400208-6EE5FFCD-FCD1-4812-8029-96619408368A Q34413018-20CAA00F-8CE8-4F47-AA4A-13D34255780E Q34424886-3F50ECAC-0F80-4DCF-B680-E0F8F37AD495 Q34600369-47F6DAA0-1AE9-4838-9330-CC4F0A57029A Q34634263-73CC25E9-E026-4098-A7EC-0B42AD05E407

P2860

Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16

http://www.wikidata.org/entity/Q33602223

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

name

Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16

@ast

Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16

@en

type

label

Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16

@ast

Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16

@en

prefLabel

Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16

@ast

Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16

@en

P1433

Q33602223-899DC682-5C44-4FC7-9468-71FC92FCE3A3

P1476

Q33602223-E8E34AA2-4BFB-420F-91DA-EAA3160E1C05

P2093

Q33602223-13CC3FA2-B51B-4BF6-986F-E397A7424382

Q33602223-167CEE71-FF7A-45F8-AB32-B786802054FD

Q33602223-3C4C707D-49B6-4193-B783-E16B06D4FBF5

Q33602223-434ADDA1-2C7C-4BC5-9D32-A4F194D41C8A

Q33602223-761BE24C-C503-4D32-A3EA-999ADF410AF0

Q33602223-E4760D64-3DD0-4782-8807-54A3A79B2A20

P2860

Q33602223-0E513813-3548-4920-9CEC-C227F0BD687E

Q33602223-352DA099-7715-4358-9052-315243FE582F

Q33602223-50590806-A6EF-4E8F-94B4-40F5011F2976

Q33602223-542506A5-5CE6-4134-B8A5-3E13A07610F4

Q33602223-6BFD2F80-0E00-4278-9219-052603B5C91B

Q33602223-769759C6-7560-4764-853D-AD2FF3A61979

Q33602223-7F536C1A-3475-4F64-A8FF-D280D625734C

Q33602223-9312D526-0AC1-4A90-BC8E-CAF77E243B10

Q33602223-93BB7E4C-47BD-4680-B250-D1F22B8FD67A

Q33602223-B632782C-179C-4632-A4DC-8F8E1FD1E96B

P304

Q33602223-AC4E948C-77AD-4E07-9292-3D9228FEA48A

P31

Q33602223-27336FE3-6A0F-45A0-BF02-2E5C6E5FF66F

P356

Q33602223-43041EDF-8DC2-4344-9624-09EE2DAC6B9A

P407

Q33602223-04257D9D-CC8A-4517-98E6-96D7F3F225C3

P433

Q33602223-06FB0FA2-5A40-4962-A2F2-4D2AD6FC9703

P478

Q33602223-765F293E-331E-4ADB-9CD6-EE24FEC19A62

P577

Q33602223-3520683F-207B-439E-ACFE-0A0F0A37EB8C

P5875

Q33602223-FD5624BA-E9DD-4575-B920-F88486F13237

P698

Q33602223-75E29450-3BE5-452C-B552-0D71CAA65A99

P921

Q33602223-0409D842-CCAF-4706-AC38-835D147CF8ED

Q33602223-D32E16B8-3171-46DA-9D1B-D874637449C7

P932

Q33602223-0CA36DA3-1635-4EE2-A902-A1356A1AACB8

P356

P1433

P1476

Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16

@en

P2093

Gijs W D Landman

http://www.w3.org/2001/XMLSchema#string

Henk J G Bilo

http://www.w3.org/2001/XMLSchema#string

Klaas H Groenier

http://www.w3.org/2001/XMLSchema#string

Kornelis J J van Hateren

http://www.w3.org/2001/XMLSchema#string

Nanne Kleefstra

http://www.w3.org/2001/XMLSchema#string

Rijk O B Gans

http://www.w3.org/2001/XMLSchema#string

P2860

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

Metformin and reduced risk of cancer in diabetic patients

Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women.

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes.

Antidiabetic therapies affect risk of pancreatic cancer.

Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer.

New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes.

Metformin use and prostate cancer in Caucasian men: results from a population-based case-control study.

Excess risk of primary liver cancer in patients with diabetes mellitus.

The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.

P304

322-326

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC09-1380

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

2009-11-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38093852

http://www.w3.org/2001/XMLSchema#string

P698

19918015

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

2809274

http://www.w3.org/2001/XMLSchema#string